Stockreport

Regenxbio's Gene Therapy for Hunter Syndrome Fails to Win FDA Approval [Yahoo! Finance]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF Regenxbio (RGNX) said late Monday the US Food and Drug Administration did not approve its biologics [Read more]